Skip to content

Evaluation of New Feedback Canceller for Carina™ Implant

Evaluation of a New Feedback Canceller Algorithm for Patient With Moderate to Severe Hearing Loss Implanted With a Fully Implantable Carina™ Medical Device

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02309541
Enrollment
12
Registered
2014-12-05
Start date
2015-02-28
Completion date
2017-09-30
Last updated
2017-10-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hearing Loss

Keywords

middle ear implant, feedback manager, Sound quality

Brief summary

The purpose of this study is to evaluate audio quality benefit for the patient implanted with a Cochlear or Otologics Carina implant with the new firmware (feedback canceller algorithm) whatever the patient environment is and to evaluate the functional gain and speech understanding benefit for the patient upon the firmware used (new and reference firmware). The new firmware aims to adapt automatically for feedback cancellation without prior calibration.

Interventions

DEVICEfeedback canceller algorithm (Firmware)

The study consists of two phases. Phase 1: optimization of parameters of new feedback canceller algorithm. Phase 2: comparison of new and reference feedback canceller algorithms.

Sponsors

Cochlear
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* successfully implanted with a commercial available CE-labelled implant device, resulting in measurable open set speech understanding * native speaker in the language used to assess their clinical performance, i.e. French

Exclusion criteria

* unwillingness or inability to comply with all of the investigational requirements * additional handicaps that would prevent or restrict participation in the audiological evaluations

Design outcomes

Primary

MeasureTime frame
Sound quality benefit assessed via subjective patient evaluation with Abbreviated Profile of Hearing Aid Benefit questionnaire1 month

Secondary

MeasureTime frame
Improvement in speech understanding assessed via speech audiometry in noise1 month

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026